Aliases:This biomarker is also known as:
- tripartite motif-containing 22,
- stimulated trans-acting factor (50 kDa),
- EC 6.3.2.-,
- 50 kDa-stimulated trans-acting factor,
- tripartite motif protein TRIM22,
- E3 ubiquitin-protein ligase TRIM22,
- Tripartite motif-containing protein 22,
- tripartite binding motif 22,
- tripartite motif-containing protein 22,
- tripartite motif containing 22,
- RING finger protein 94,
tripartite motif containing 22
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
No additional prostate data available.
Significance Analysis of Microarray (SAM) was used to develop a 7-gene classifier. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively This prognostic signature is closely associated with biochemical recurrence in patients after radical prostatectomy. The seven genes are: RRAGD, PQBP1, HIST1H2BC, ALDH1A2, TRIM22, RBPMS, HSPB8.